Posted on 9/19/16
Where Will Procter & Gamble Co Stock Be 1 Year From Now?
Procter & Gamble (NYSE:PG) shareholders have had a great 12 months. The consumer goods titan's stock is up nearly 30% since last September, making it the . . .
Posted on 9/18/16
Roka Bioscience Prices Private Placement of Preferred Stock and Warrants
Roka Bioscience, Inc. (ROKA), a molecular diagnostics company focused on providing advanced testing solutions for the detection of foodborne pathogens, today announced that it has entered . . .
Posted on 9/18/16
Immune Pharmaceuticals Signs Agreement to Fund Maxim Pharmaceuticals its Pain and Neurology Subsidiary
Immune Pharmaceuticals Inc. (NASDAQ: IMNP), a biopharmaceutical company focused on the development of targeted therapeutics for the treatment of inflammatory diseases and cancer, announced today that . . .
Posted on 9/16/16
Better Buy: Pfizer Inc. vs. AbbVie Inc.
IMAGE SOURCE: GETTY IMAGES.Big pharma is on a roll.Several of the largest drugmakers' stocks are up by double-digit percentages over the past six months. Count AbbVie . . .
Posted on 9/16/16
5 Reasons Celgene Is a Buy
IMAGE SOURCE: CELGENE While the past few months have been good to Celgene (NASDAQ:CELG) investors, shares are still down about 11% year to date, dramatically underperforming . . .
Posted on 9/15/16
Fidelis Care Celebrates Opening of New, Expanded Office
FAIRPORT, N.Y., Sept. 15, 2016 (GLOBE NEWSWIRE) -- As a reflection of Fidelis Care's growth and expansion in the Rochester Region, Fidelis Care celebrated the official . . .
Posted on 9/14/16
eHealth Technologies Expands Its Services at UVA Health System
ROCHESTER, N.Y.--(BUSINESS WIRE)--eHealth Technologies, the leading provider of clinically informed referral solutions, announced today that University of Virginia (UVA) Health System has expanded the eHealth Connect® . . .
Posted on 9/14/16
Ferring Pharmaceuticals Recognized as the Nation’s Most Adoption-Friendly Workplace by Dave Thomas Foundation for Adoption
PARSIPPANY, N.J.--(BUSINESS WIRE)--Ferring Pharmaceuticals was recognized as the most Adoption-Friendly Workplace in the United States by the Dave Thomas Foundation for Adoption, America’s only nonprofit public . . .
Posted on 9/14/16
IMS Health Prices Notes Offering
DANBURY, Conn. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IMS Health Holdings, Inc. (NYSE:IMS) today announced the pricing of its offering of $1.75 billion equivalent in gross proceeds . . .
Posted on 9/14/16
Why Pfizer's Stock Is a Big Gamble Right Now
IMAGE SOURCE: GETTY IMAGES.Since the failure of Pfizer's (NYSE:PFE) $160 billion megadeal to buy Allergan and move its headquarters, on paper, to lower-tax Ireland, shares of . . .
Posted on 9/13/16
Matinas BioPharma Completes Private Placement of $8.0 Million
BEDMINSTER, N.J., Sept. 13, 2016 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (OTCQB:MTNB), a clinical-stage biopharmaceutical company focused on identifying and developing safe and effective broad . . .
Posted on 9/14/16
Reproductive Medicine Associates of New Jersey to Offer Free Physicians' Webinar Series on Infertility
Five-Part Series to Feature Q&A and cover topics such as IUI, IVF, Egg Freezing, AMH Screening, LGBT Family Building, Fertility Financials, and morePhysicians from Reproductive Medicine Associates . . .
Posted on 9/13/16
Ember Therapeutics Acquires Dermasilk Brands
NEW YORK, Sept. 12, 2016 (GLOBE NEWSWIRE) -- Ember Therapeutics, Inc. (OTCQB:EMBT), a diversified New York-based pharmaceutical company developing targeted therapies for osteoarthritis, kidney fibrosis, and . . .
Posted on 9/13/16
IMS Health Announces Notes Offering
DANBURY, Conn. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IMS Health Holdings, Inc. (NYSE:IMS) today announced that its wholly owned subsidiary, IMS Health Incorporated, intends to raise $1.5 . . .
Posted on 9/13/16
Q BioMed Closes Licensing Agreement for FDA Approved Drug - Vows to Lower Drug Price
Q BioMed Inc, a New York City-based biotechnology acceleration company recently closed on an exclusive license and option agreement for a FDA approved generic drug, Strontium . . .
Posted on 9/12/16
3 All-or-Nothing Biotechs I'm Watching Like a Hawk
IMAGE SOURCE: GETTY IMAGES.Every small-cap biotech stock whose future depends on the success of a single compound will eventually face a binary event. Whether that event . . .
Posted on 9/12/16
3 Stocks to Avoid in the Biotechnology Sector
IMAGE SOURCE: GETTY IMAGES.Perhaps more than any other industry, biotechnology start-ups face long, treacherous paths to profitability, and a majority never make it. If you think . . .
Posted on 9/12/16
Pfizer Takes Aim at Johnson & Johnson
IMAGE SOURCE: GETTY IMAGES.Johnson & Johnson (NYSE:JNJ) is a global healthcare giant that's well known for top-selling consumer brands like Band-Aid, but it also generates billions . . .
Posted on 9/9/16
AArete Adds John Marchisin as Managing Director
AArete LLC has added John Marchisin, a 25-year veteran of the healthcare provider industry, as a Managing Director.Marchisin, based in New York, provides profit improvement services . . .
Posted on 9/9/16
This Crushing Blow Sent Bristol-Myers Squibb Co. Down 23% in August
IMAGE SOURCE: GETTY IMAGES.What happenedShares of Bristol-Myers Squibb (NYSE:BMY), a global drug developer focused on the development cancer, cardiovascular, and genetic-defined disease drugs, plunged 23% in . . .
Posted on 9/9/16
Is Pfizer About to Slash Its Dividend?
It's no secret that Pfizer (NYSE:PFE) has been gearing up for a possible split for several years now. And, in its most recent efforts to this . . .
Posted on 9/9/16
Merck & Co's (MRK) Management Presents at Wells Fargo Healthcare Conference
Merck & Co Inc. (NYSE:MRK)Wells Fargo Healthcare ConferenceSeptember 8, 2016 01:45 PM ETExecutivesRoger Dansey - SVP, Clinical Research of OncologyTeri Loxam - VP, IRAnalystsDavid Maris - . . .
Posted on 9/9/16
Johnson & Johnson (JNJ) Management Presents at Wells Fargo Securities Research, Economics & Strategy 2016 Healthcare Conference - Transcript
Johnson & Johnson (NYSE:JNJ)Wells Fargo Securities Research, Economics & Strategy 2016 Healthcare ConferenceSeptember 8, 2016, 10:30 AM ETExecutivesDominic Caruso - Executive Vice President and Chief Financial . . .
Posted on 9/9/16
Johnson & Johnson - How To Quit Working In 8 Years With $1.5M In Savings
Assumptions on living costs, net earnings, and savings for investmentLiving costsThe aim of building savings rapidly requires a willingness to scrimp and save on living costs . . .
Posted on 9/8/16
Immune Pharmaceuticals Receives $2 Million Investment in Common Stock
Immune Pharmaceuticals Inc. (NASDAQ: IMNP), a biopharmaceutical company focused on the development of targeted therapeutics for the treatment of inflammatory diseases and cancer, announced today that . . .
New York
